Pfizer Earnings Above, Third Quarter Revenues Down

Investing.com – Pfizer (NYSE:PFE) on Tuesday reported third-quarter earnings that topped analyst expectations and revenue that was below forecasts.

The company reported earnings per share of $0.78 on revenue of $13.3 billion. Analysts surveyed by Investing.com were expecting earnings of $0.75 per share on revenue of $13.55 billion. That compared to earnings per share of $0.67 on revenue of $12.90 billion in the same period a year earlier. The company reported earnings per share of $0.81 on revenue of $13.47 billion in the previous quarter.

Pfizer shares are up 19.35% for the year, outperforming the S&P Global (NYSE:SPGI) 100 Index, which is down 3.51% year-to-date.

Pfizer is tracking the performance of other major healthcare sectors this month

On October 16, J&J (NYSE:JNJ) announced third-quarter earnings of $2.05 on revenue of $20.35 billion, while it had forecast earnings per share of $2.03 on revenue of $20. 05 billion USD.

Novartis ADR earnings exceeded analyst expectations on October 18, with third-quarter earnings per share of $1.32 on revenue of $12.78 billion. Analysts at Investing.com expected earnings of $1.3 per share on revenue of $12.94 billion

Stay up to date with all upcoming earnings reports by visiting the earnings calendar on Investing.com

Coca-Cola ranks first in sales estimates

Coca-Cola’s profits, revenues improve in Q3

Fidelity National Info Profits soar, third-quarter revenue down